Try our beta test site
1 study found for:    11781247 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
Condition: Untreated T-cell Angioimmunoblastic Lymphoma
Interventions: Drug: Rituximab;   Drug: Prednisone;   Drug: Doxorubicine;   Drug: Cyclophosphamide;   Drug: Vincristine

Study has passed its completion date and status has not been verified in more than two years.